Blue biotechnology, also known as marine biotechnology, is a rapidly growing field that involves the use of marine organisms and their derivatives for various applications, including pharmaceuticals, food, and energy production. The potential of blue biotechnology is enormous, as the oceans cover more than 70% of the Earth’s surface and are home to a vast array of unique and diverse marine life.<\/p>\n
To accelerate innovation in blue biotechnology, the European Union has launched the Blue Bio Value Acceleration Programme 2023. This programme aims to support the development of innovative and sustainable blue biotechnology products and services by providing funding, mentoring, and networking opportunities to startups and SMEs in the field.<\/p>\n
The Blue Bio Value Acceleration Programme 2023 is a three-year initiative that will run from 2021 to 2023. It is funded by the European Maritime and Fisheries Fund and is managed by a consortium of partners, including the Portuguese Sea and Atmosphere Institute (IPMA), the University of Bergen, and the Norwegian University of Science and Technology (NTNU).<\/p>\n
The programme is open to startups and SMEs from all over Europe that are working on innovative blue biotechnology products or services. The selected participants will receive funding of up to \u20ac45,000, as well as access to mentoring and coaching from experts in the field. They will also have the opportunity to network with other startups and SMEs in the blue biotechnology sector, as well as with potential investors and customers.<\/p>\n
The Blue Bio Value Acceleration Programme 2023 is divided into three phases. In the first phase, which runs from January to June 2021, participants will receive training and coaching on business development, market analysis, and intellectual property rights. They will also have the opportunity to pitch their ideas to a panel of experts and investors.<\/p>\n
In the second phase, which runs from July 2021 to June 2022, participants will receive funding of up to \u20ac30,000 to develop their products or services. They will also receive mentoring and coaching on product development, regulatory compliance, and marketing.<\/p>\n
In the third and final phase, which runs from July 2022 to June 2023, participants will receive funding of up to \u20ac15,000 to bring their products or services to market. They will also receive mentoring and coaching on sales and distribution, as well as access to potential customers and investors.<\/p>\n
The Blue Bio Value Acceleration Programme 2023 is an excellent opportunity for startups and SMEs in the blue biotechnology sector to accelerate their innovation and bring their products or services to market. It provides funding, mentoring, and networking opportunities that can help them overcome the challenges of developing and commercializing innovative blue biotechnology products and services.<\/p>\n
In conclusion, the Blue Bio Value Acceleration Programme 2023 is a significant initiative that can help accelerate innovation in blue biotechnology and contribute to the sustainable development of the blue economy. It is an excellent opportunity for startups and SMEs in the field to receive funding, mentoring, and networking opportunities that can help them bring their innovative products and services to market.<\/p>\n
Blue biotechnology, also known as marine biotechnology, is a rapidly growing field that involves the use of marine organisms and their derivatives for various applications, including pharmaceuticals, food, and energy production. The potential of blue biotechnology is enormous, as the oceans cover more than 70% of the Earth’s surface and are home to a vast […]<\/p>\n","protected":false},"author":2,"featured_media":2544663,"menu_order":0,"template":"Default","format":"standard","meta":[],"aiwire-tag":[676,1147,925,2012,1892,6321,560,1573,11,441,17,132,1311,18,134,20,7982,21,5727,6197,5214,2549,724,12979,29,219,220,2170,12494,973,2336,18081,1182,2716,590,4388,156,1780,867,1745,1782,6387,455,21676,1196,1747,4428,2722,17447,2577,459,6232,2192,461,381,3237,16606,743,13598,1897,50,2073,51,7191,1625,4873,52,243,55,245,1968,1799,57,389,1232,1426,1427,6673,6784,6785,7058,477,752,172,2817,60,61,2484,482,2818,249,484,393,2233,2319,15912,68,18671,1344,24076,69,73,1443,16677,6018,26552,75,78,488,1257,1853,184,185,10236,2648,1810,1260,9479,2004,6485,3803,5,10,7,8,82,20544,5929,629,1812,831,1813,5126,2970,88,661,90,1359,1100,6492,6059,3850,496,774,6803,21363,6737,1283,1113,1759,1114,99,8179,1369,639,840,2523,21186,204,107,108,109,110,206,1127,1720,1721,111,424,5797,117,1471,844,307,1730,1136,3323,9,212,124,125,341,6],"aiwire":[2122],"_links":{"self":[{"href":"https:\/\/platoai.gbaglobal.org\/wp-json\/wp\/v2\/platowire\/2544678"}],"collection":[{"href":"https:\/\/platoai.gbaglobal.org\/wp-json\/wp\/v2\/platowire"}],"about":[{"href":"https:\/\/platoai.gbaglobal.org\/wp-json\/wp\/v2\/types\/platowire"}],"author":[{"embeddable":true,"href":"https:\/\/platoai.gbaglobal.org\/wp-json\/wp\/v2\/users\/2"}],"version-history":[{"count":0,"href":"https:\/\/platoai.gbaglobal.org\/wp-json\/wp\/v2\/platowire\/2544678\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/platoai.gbaglobal.org\/wp-json\/wp\/v2\/media\/2544663"}],"wp:attachment":[{"href":"https:\/\/platoai.gbaglobal.org\/wp-json\/wp\/v2\/media?parent=2544678"}],"wp:term":[{"taxonomy":"aiwire-tag","embeddable":true,"href":"https:\/\/platoai.gbaglobal.org\/wp-json\/wp\/v2\/aiwire-tag?post=2544678"},{"taxonomy":"aiwire","embeddable":true,"href":"https:\/\/platoai.gbaglobal.org\/wp-json\/wp\/v2\/aiwire?post=2544678"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}